Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Haverkate

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Letter: The fibrin plate assay -- some crucial conditionsF Haverkate, P Brakman
Haemostasis|July 27, 1999
Specificity of haemostasis abnormalities for vascular phenotypesG D Lowe, F Haverkate
Thrombosis Et Diathesis Haemorrhagica|December 31, 1974
Dose-response curves in the fibrin plate assay. Fibrinolytic acitivity of proteasesF Haverkate, D W Traas
European Journal of Clinical Investigation|August 1, 1979
Anticlotting properties of fragments D from human fibrinogen and fibrinF Haverkate, G Timan, W Nieuwenhuizen
Biochimica Et Biophysica Acta|February 27, 1981
Factors influencing the structure of terminal plasmin degradation products of human fibrinogen and fibrinW Nieuwenhuizen, A Vermond, F Haverkate
Thrombosis and Haemostasis|April 1, 1995
Haemostasis factors in angina pectoris; relation to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study GroupF Haverkate, S G Thompson, F Duckert
Thrombosis Research|September 1, 1983
Granulocyte enzyme mediated degradation of human fibrinogen in plasma in vitroL Sterrenberg, M Gravesen, F Haverkate, et al.
Lancet (London, England)|May 21, 1998
Statins and fibrinogenF Haverkate, J Koopman, M P de Maat
The Journal of Biological Chemistry|July 15, 1991
A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerizationJ Koopman, F Haverkate, E Briët, et al.
FEBS Letters|February 15, 1979
Calcium-binding properties of human fibrin(ogen) and degradation productsW Nieuwenhuizen, A Vermond, W J Nooijen, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Letter: The fibrin plate assay -- some crucial conditionsF Haverkate, P Brakman
Haemostasis|July 27, 1999
Specificity of haemostasis abnormalities for vascular phenotypesG D Lowe, F Haverkate
Thrombosis Et Diathesis Haemorrhagica|December 31, 1974
Dose-response curves in the fibrin plate assay. Fibrinolytic acitivity of proteasesF Haverkate, D W Traas
European Journal of Clinical Investigation|August 1, 1979
Anticlotting properties of fragments D from human fibrinogen and fibrinF Haverkate, G Timan, W Nieuwenhuizen
Biochimica Et Biophysica Acta|February 27, 1981
Factors influencing the structure of terminal plasmin degradation products of human fibrinogen and fibrinW Nieuwenhuizen, A Vermond, F Haverkate
Thrombosis and Haemostasis|April 1, 1995
Haemostasis factors in angina pectoris; relation to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study GroupF Haverkate, S G Thompson, F Duckert
Thrombosis Research|September 1, 1983
Granulocyte enzyme mediated degradation of human fibrinogen in plasma in vitroL Sterrenberg, M Gravesen, F Haverkate, et al.
Lancet (London, England)|May 21, 1998
Statins and fibrinogenF Haverkate, J Koopman, M P de Maat
The Journal of Biological Chemistry|July 15, 1991
A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerizationJ Koopman, F Haverkate, E Briët, et al.
FEBS Letters|February 15, 1979
Calcium-binding properties of human fibrin(ogen) and degradation productsW Nieuwenhuizen, A Vermond, W J Nooijen, et al.
Pageof 8